Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
Eledon Pharmaceuticals
ELDN
$260M
| $1.91M | ﹤0.01% |
485,092
+339,934
| +234% | +$1.24M |
|
4777
Electromed
ELMD
$248M
| $1.91M | ﹤0.01% |
45,180
-784
| -2% | -$25.1K |
|
|
IRD
4778
Opus Genetics
IRD
$307M
| $1.91M | ﹤0.01% |
464,900
+425,378
| +1,076% | +$1.98M |
|
4779
RPAR Risk Parity ETF
RPAR
$584M
| $1.91M | ﹤0.01% |
85,747
-961
| -1% | -$21.9K |
|
4780
Hartford Core Bond ETF
HCRB
$407M
| $1.9M | ﹤0.01% |
54,391
+10,472
| +24% | +$367K |
|
|
NEE.PRT
4781
NextEra Energy 7.234% Corporate Units
NEE.PRT
$1.43B
| $1.9M | ﹤0.01% |
38,265
+7,837
| +26% | +$401K |
|
4782
Silvercrest Asset Management
SAMG
$78.9M
| $1.9M | ﹤0.01% |
187,944
+103,852
| +123% | +$1.26M |
|
|
SVAC
4783
DELISTED
Spring Valley Acquisition Corp III
SVAC
| $1.9M | ﹤0.01% |
185,050
-21
| -0% | -$218 |
|
4784
SEACOR Marine Holdings
SMHI
$255M
| $1.9M | ﹤0.01% |
248,053
-4,258
| -2% | -$31.6K |
|
4785
Velocity Financial
VEL
$711M
| $1.89M | ﹤0.01% |
102,530
+14,080
| +16% | +$256K |
|
|
ZTR
4786
Virtus Total Return Fund
ZTR
$342M
| $1.89M | ﹤0.01% |
276,486
-13,334
| -5% | -$90.1K |
|
|
ECF
4787
Ellsworth Growth & Income Fund
ECF
$170M
| $1.89M | ﹤0.01% |
142,802
-1,545
| -1% | -$19.6K |
|
4788
Fiverr
FVRR
$340M
| $1.88M | ﹤0.01% |
182,187
-205,193
| -53% | -$2.18M |
|
4789
Stoneridge
SRI
$205M
| $1.88M | ﹤0.01% |
256,804
+15,329
| +6% | +$105K |
|
|
NBTX
4790
Nanobiotix
NBTX
$2.09B
| $1.88M | ﹤0.01% |
49,789
+13,515
| +37% | +$503K |
|
4791
Fate Therapeutics
FATE
$291M
| $1.88M | ﹤0.01% |
694,580
-73,168
| -10% | -$135K |
|
4792
The Honest Company
HNST
$608M
| $1.86M | ﹤0.01% |
509,428
+211,777
| +71% | +$714K |
|
4793
First Internet Bancorp
INBK
$245M
| $1.86M | ﹤0.01% |
66,896
+22,674
| +51% | +$550K |
|
4794
Rackspace Technology
RXT
$803M
| $1.85M | ﹤0.01% |
283,739
+36,695
| +15% | +$143K |
|
|
CGC
4795
Canopy Growth
CGC
$449M
| $1.85M | ﹤0.01% |
1,946,294
-23,346
| -1% | -$24.8K |
|
|
RFM
4796
RiverNorth Flexible Municipal Income Fund
RFM
$87.9M
| $1.84M | ﹤0.01% |
124,718
+8,374
| +7% | +$121K |
|
4797
Lexeo Therapeutics
LXEO
$399M
| $1.84M | ﹤0.01% |
395,102
-7,822
| -2% | -$42.3K |
|
4798
ARS Pharmaceuticals
SPRY
$586M
| $1.84M | ﹤0.01% |
229,100
-87,573
| -28% | -$753K |
|
4799
Bioventus
BVS
$945M
| $1.83M | ﹤0.01% |
193,734
-65,067
| -25% | -$621K |
|
4800
TriSalus Life Sciences
TLSI
$297M
| $1.83M | ﹤0.01% |
401,814
+7,905
| +2% | +$31.4K |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.